Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Identification of a pharmaceutical degrader of peroxiredoxin 4

FY 2024-25

Summary
Pancreatic cancer is one of the deadliest types of cancer; only 10% of patients will be alive 5 years after their diagnosis. The only potential cure is surgery, but pancreatic cancer remains hidden for so long that once it finally diagnosed, 80% of patients cancers are too advanced for surgery to be a viable option. Therefore, new therapies are urgently needed. Peroxiredoxin 4 (PRDX4) is an important protein in pancreatic cancer; research suggests that up to half of pancreatic cancers will not grow without it. However, normal cells function well without PRDX4. Therefore, a drug which reduces the amount of PRDX4 in the cell is promising because it could kill cancer cells all over the body without harming normal cells - something only a handful of cancer drugs have ever been able to do. Recently, the drug pelitinib was identified as a potential PRDX4 degrader. Degraders are a cutting-edge class of drug that work by binding a protein and causing it to be degraded by the cell own waste disposal machinery. My project centres around identifying and optimizing potential PRDX4 degraders. I will test whether pelitinib degrades PRDX4 in pancreatic cancer. If it does, we will chemically modify it to make its activity stronger and more specific to PRDX4. I will also optimize and perform an experiment which involves anchoring PRDX4 to a metal film and mixing it with various chemical compounds. If any of those compounds bind to PRDX4, the metal film will reflect light differently. This experiment is simple and efficient, which will allow me to test thousands of chemical compounds and identify candidates that can be chemically modified into a high-quality PRDX4 degrader.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530256
Name
Fu Norman J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of a pharmaceutical degrader of peroxiredoxin 4
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Drug Discovery; Fragment-Based Drug Design; High-Throughput Screening; Pancreatic Cancer; Pelitinib (Ekb-569); Peroxiredoxin 4; Proximity-Inducing Pharmacology; Surface Plasmon Resonance; Targeted Protein Degradation
Abstract
Pancreatic cancer is one of the deadliest types of cancer; only 10% of patients will be alive 5 years after their diagnosis. The only potential cure is surgery, but pancreatic cancer remains hidden for so long that once it finally diagnosed, 80% of patients cancers are too advanced for surgery to be a viable option. Therefore, new therapies are urgently needed. Peroxiredoxin 4 (PRDX4) is an important protein in pancreatic cancer; research suggests that up to half of pancreatic cancers will not grow without it. However, normal cells function well without PRDX4. Therefore, a drug which reduces the amount of PRDX4 in the cell is promising because it could kill cancer cells all over the body without harming normal cells - something only a handful of cancer drugs have ever been able to do. Recently, the drug pelitinib was identified as a potential PRDX4 degrader. Degraders are a cutting-edge class of drug that work by binding a protein and causing it to be degraded by the cell own waste disposal machinery. My project centres around identifying and optimizing potential PRDX4 degraders. I will test whether pelitinib degrades PRDX4 in pancreatic cancer. If it does, we will chemically modify it to make its activity stronger and more specific to PRDX4. I will also optimize and perform an experiment which involves anchoring PRDX4 to a metal film and mixing it with various chemical compounds. If any of those compounds bind to PRDX4, the metal film will reflect light differently. This experiment is simple and efficient, which will allow me to test thousands of chemical compounds and identify candidates that can be chemically modified into a high-quality PRDX4 degrader.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fu, Norman J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~